PaullJ.D., FortuneD.W.Hepatotoxicity and death following two enflurane anaesthetics. Anaesthesia1987; 42: 1191–1196.
2.
ServinF.Diprivan et foie. Ann Franc d'Anesthésie Réanimation1994; 13(4): 477–479.
3.
CarmichaelF.J., CrawfordM.W., KhayyamN., SaldiviaV.Effect of propofol infusion on splanchnic hemodynamics and liver oxygen consumption in the rat. A dose-response study. Anesthesiology1993; 79(5): 1051–1060.
4.
HabererJ.P., AudibertG., SaunierC.G., MullerC., LaxenaireM.C., HartemannD.Effect of propofol and thiopentone on regional blood flow in brain and peripheral tissues during normoxia and hypoxia in the dog. Clin Physiol1993; 13(2): 197–207.
5.
RobinsonF.P., PattersonC.C.Changes in liver function tests after propofol (“Diprivan”). Post Med Journal1985; 61(Suppl. 3): 160–161.
6.
StarkR.D., BinksS.M., DutkaV.N., O'ConnorK.M., ArnsteinM.J.A., GlenJ.B.A review of the safety and tolerance of propofol (“Diprivan”). Post Med Journal1985; 61(Suppl. 3): 152–156.
7.
MurrayJ.M., PhillipsA.S., FeeJ.P.Comparison of the effects of isoflurane and propofol on hepatic glutathione-S-transferase concentrations during and after prolonged anaesthesia. Br J Anaesthesia1994; 72(5): 599–601.
8.
LewisJ.H., ZimmermanH.J., IshakK.G., MullickF.G.Enflurane hepatotoxicity: A clinicopathologic study of 24 cases. Ann Int Med1983; 98: 984–992.
ElliotR.H., StruninL.Hepatotoxicity of volatile anaesthetics. Br J Anaesth1993; 70: 339–348.
12.
KennaJ.G., NeubergerJ., WilliamsR.Specific antibodies to halothane induced liver antigens in halothane associated hepatitis. Br J Anaesth1987; 59: 1286–1290.
13.
SigurdssonJ., HreidarssonA.B., ThjodleifssonB.Enflurane hepatitis. A report of a case with a previous history of halothane hepatitis. Acta Anaesthesiol Scand1985; 29: 495–496.
14.
ChristD.D., KennaJ.G., KammererW., SatohH., PohlL.R.Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis. Anesthesiology1988; 69: 833–838.
